Encefalopatía aguda en un paciente tratado con inmunoglobulina endovenosa por un síndrome de Guillain-Barré / Acute encephalopathy associated with the use of intravenous immunoglobulin. Report of one case
Rev. méd. Chile
;
139(10): 1340-1343, oct. 2011. ilus
Artigo
em Espanhol
| LILACS
| ID: lil-612203
ABSTRACT
Adverse reactions to intravenous immunoglobulin (ivIg) therapy, such as anaphylaxis, acute encephalopathy, aseptic meningitis, or thrombotic phenomena are uncommon. We report a 58-year-old man with hypertension presenting with muscle weakness which led to paraparesia and respiratory failure. With the diagnosis of Guillain-Barré syndrome (GBS), he was treated with ivIg. He developed an acute encephalopathy few hours after the administration of ivIg, with a decreased level of consciousness and agitation. A CT scan revealed moderate and diffuse brain edema. Encephalopathy resolved 96 hours after ivIg withdrawal and use of plasma exchange. A CT scan performed seven days after showed the resolution of brain edema.
Texto completo:
DisponíveL
Índice:
LILACS (Américas)
Assunto principal:
Edema Encefálico
/
Imunoglobulinas Intravenosas
/
Síndrome de Guillain-Barré
Tipo de estudo:
Fatores de risco
Limite:
Humanos
/
Masculino
Idioma:
Espanhol
Revista:
Rev. méd. Chile
Assunto da revista:
Medicina
Ano de publicação:
2011
Tipo de documento:
Artigo
País de afiliação:
Chile
Instituição/País de afiliação:
Universidad de Chile/CL
Similares
MEDLINE
...
LILACS
LIS